MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/09546634.2025.2574307

Медицинская библиотека · The Journal of dermatological treatment · 2025

Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.

Xu Zhongyi, Xuan Yijie, Zhu Zhe, Ding Yuecen, Jin Shanglin, He Xuanxuan, Xiang Leihong, Zhang Chengfeng

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Janus kinase (JAK) inhibitors, such as abrocitinib, are emerging alternatives to glucocorticoids for treating progressive non-segmental vitiligo (NSV), though long-term data remain limited.

OBJECTIVE

To assess 52-week efficacy and safety of oral abrocitinib with narrow-band ultraviolet B (NB-UVB) phototherapy in progressive NSV.

METHODS

Eleven patients with progressive NSV, resistant to systemic glucocorticoids treatment, received abrocitinib (100 mg/day) for 16 weeks, followed by 100 mg every other day for 36 additional weeks. NB-UVB phototherapy was performed twice weekly. Response was assessed using the Total Vitiligo Area Severity Index (T-VASI) and Facial Vitiligo Area Severity Index (F-VASI). Serum biomarkers and adverse events (AEs) were monitored.

RESULTS

Median improvement increased from 29.2% (IQR 8.8%-38.6%) at week 24 to 39.6% (IQR 27.7%-47.8%) at week 52 (p = 0.043). By week 24, 54.5% achieved T-VASI25, improving to 72.7% by week 52. Non-responders at week 24 showed no further improvement at week 52. Serum CCL20 decreased at weeks 24 and 52 (p = 0.0003), while CXCL10 and IFN-γ remained unchanged. Mild AEs (headache, dizziness, nausea) were reported and no severe AE was observed.

CONCLUSION

Long-term abrocitinib plus NB-UVB phototherapy demonstrates sustained efficacy and safety in progressive NSV, though non-responders by 24 weeks may not benefit from extension.

Для цитирования: Xu Zhongyi, Xuan Yijie, Zhu Zhe, Ding Yuecen, Jin Shanglin, He Xuanxuan, Xiang Leihong, Zhang Chengfeng. Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective study.. The Journal of dermatological treatment. 2025. DOI: 10.1080/09546634.2025.2574307.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.